Medication info
Dezaltan 16 mg (Candesartan Cilexetil)

Dezaltan 16 mg (Candesartan Cilexetil)

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›16mg / 1 tablet
Manufacturer / importer
Hanmi Pharmaceutical Co., Ltd.
Appearance
Light pink tablets that are convex on both sides with a line on one side.
Packaging
1 bottle/box [30 tablets/bottle], 1 bottle/box [300 tablets/bottle]
Approval status
Active

MFDS item code 201101757 · Approved 2011.03.29 · Insurance code 643505900

Summary

Main use
Treatment of essential hypertension and heart failure with reduced left ventricular systolic function
Who takes it
Adults · Children
Adult dose
(Tablets) Take this medicine at the same time each day, with or without food. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, another treatment should be considered. The maximum effect occurs within 4 weeks of starting treatment. 2) Elderly patients: No adjustment of the initial dose is necessary. 3) Patients with reduced effective intravascular volume (Intravascular volume depletion): Administer an initial dose of 4 mg, with careful monitoring in patients at increased risk of hypotension, such as those with reduced effective blood volume. 4) Patients with renal impairment: The initial dose in patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose in patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: An initial dose of 4 mg once daily is recommended. Double the dose at intervals of at least 2 weeks; the dose may be increased to a maximum of 32 mg once daily, according to the patient's tolerability. 2) Elderly patients, patients with reduced effective intravascular volume, patients with renal impairment, and patients with mild ∼ moderate hepatic impairment: No adjustment of the initial dose is necessary.
Child dose
1. Essential hypertension 6) Pediatric patients: The safety and efficacy in adolescents and children aged 18 years and younger have not been established. 2. Heart failure 3) Pediatric patients: The safety and efficacy in adolescents and children aged 18 years and younger have not been established.

Ingredients

Manufacturer
Hanmi Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and heart failure with reduced left ventricular systolic function

  • Essential hypertension
  • impaired left ventricular function
  • heart failure
View approved original text

This medication effectively lowers blood pressure in patients with essential hypertension, aiding in blood pressure management. It is also used in heart failure patients with impaired left ventricular function where ACE inhibitor treatment is not suitable or additional treatment is required. Particularly, it is appropriate for patients with heart failure classified in NYHA classes II to IV, and with a left ventricular ejection fraction of 40% or less. Therefore, this medication is effectively used for symptom improvement in patients with hypertension and certain types of heart failure.

How to take

Adult dose

(Tablets) Take this medicine at the same time each day, with or without food. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, another treatment should be considered. The maximum effect occurs within 4 weeks of starting treatment. 2) Elderly patients: No adjustment of the initial dose is necessary. 3) Patients with reduced effective intravascular volume (Intravascular volume depletion): Administer an initial dose of 4 mg, with careful monitoring in patients at increased risk of hypotension, such as those with reduced effective blood volume. 4) Patients with renal impairment: The initial dose in patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose in patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: An initial dose of 4 mg once daily is recommended. Double the dose at intervals of at least 2 weeks; the dose may be increased to a maximum of 32 mg once daily, according to the patient's tolerability. 2) Elderly patients, patients with reduced effective intravascular volume, patients with renal impairment, and patients with mild ∼ moderate hepatic impairment: No adjustment of the initial dose is necessary.

Child dose

1. Essential hypertension 6) Pediatric patients: The safety and efficacy in adolescents and children aged 18 years and younger have not been established. 2. Heart failure 3) Pediatric patients: The safety and efficacy in adolescents and children aged 18 years and younger have not been established.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. People who are allergic to this drug or its ingredients, pregnant or nursing women, patients with severe liver dysfunction or cholestasis, and those with a history of hereditary angioedema should not take this medication. Additionally, patients with galactose intolerance or certain genetic metabolic disorders should also avoid this drug. Elderly patients, those with hyperkalemia, patients with mild to moderate liver dysfunction, certain heart valve disease patients, and patients with impaired kidney function should use this medication cautiously, monitoring their status closely before and during administration. Side effects such as dizziness, back pain, and respiratory infections may occur; rarely, serious side effects like blood abnormalities, liver dysfunction, muscle problems, and worsening kidney function may arise. Therefore, consultation with healthcare professionals is recommended upon the appearance of abnormal symptoms. In heart failure patients, hypotension or worsening kidney function may appear during use of this medication, so regular monitoring of serum potassium and creatinine levels is advised. This drug may enhance the blood pressure-lowering effects when used with other antihypertensives, so caution is necessary during co-administration. Particularly, when taken with potassium-sparing diuretics or potassium supplements, the blood potassium level may rise to dangerous levels, requiring attention. Patients preparing for surgery or anesthesia should stop taking this medication 24 hours before the procedure. In patients with poor kidney function or heart failure, the treatment should start at a low dose and gradually increase while observing the patient's condition closely. Caution is warranted when driving or operating machinery as dizziness or drowsiness may occur. Women who are pregnant or planning to become pregnant should avoid taking this medication, and nursing mothers should also refrain from use. The safety and efficacy of this drug have not been established in children and adolescents under 18. In cases of overdose, symptoms may include hypotension, dizziness, and rapid heartbeat; in emergencies, stabilizing the patient and providing necessary treatment is required. This medication should be kept out of reach of children and transferring it to other containers is not advised as it may compromise product quality.

Side effects

  • dizziness
  • low back pain
  • respiratory infection
  • upper respiratory tract infection
  • pharyngitis
  • rhinitis
  • weakness
  • fever
  • sensory disturbance
  • indigestion
Show 71 more
  • gastroenteritis
  • tachycardia
  • palpitations
  • increased creatine kinase
  • hyperglycemia
  • hypertriglyceridemia
  • hyperuricemia
  • myalgia
  • epistaxis
  • anxiety
  • depression
  • drowsiness
  • dyspnea
  • rash
  • increased sweating
  • hematuria
  • hypotension
  • hyperkalemia
  • renal function impairment
  • increased creatinine
  • increased urea
  • fatigue
  • peripheral edema
  • chest pain
  • headache
  • bronchitis
  • cough
  • sinusitis
  • nausea
  • abdominal pain
  • diarrhea
  • vomiting
  • arthralgia
  • proteinuria
  • leukopenia
  • neutropenia
  • agranulocytosis
  • hyponatremia
  • hypoglycemia
  • seizures
  • consciousness disturbance
  • intestinal vascular edema
  • increased liver enzyme levels
  • hepatitis
  • elevated AST
  • elevated ALT
  • elevated γ-GTP
  • jaundice
  • urticaria
  • pruritus
  • angioedema
  • rhabdomyolysis
  • acute renal failure
  • interstitial pneumonia
  • shock
  • syncope
  • loss of consciousness
  • paralysis
  • hypertonia
  • facial flushing
  • weight gain
  • facial edema
  • thirst
  • sleep disturbances
  • decreased libido
  • forgetfulness
  • decreased appetite
  • increased appetite
  • tinnitus
  • taste disturbance
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication can be sensitive to air and moisture, so it must be stored in a tightly sealed container. It is recommended to maintain the storage temperature between 1 to 30 degrees Celsius. Proper storage ensures the effectiveness and safety of the medication over time.

Appearance and packaging

Appearance

Light pink tablets that are convex on both sides with a line on one side.

Package unit

1 bottle/box [30 tablets/bottle], 1 bottle/box [300 tablets/bottle]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.